Pan‐Cancer Analysis of the Prognostic and Immunological Role of AQP9: Friend or Foe?
Cancer Nexus · 2025
DOI: 10.1002/cnx2.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Nexus, 2025. Verfasst von Rui Li und 8 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The aquaporin‐9 (AQP9) has been implicated in tumorigenesis, but its pan‐cancer prognostic and immunology remain poorly understood. Therefore, we explored the role of AQP9 in pan‐cancer.
Methods
We systematically analyzed the expression of AQP9 across human cancers using multi‐omics data from The Cancer Genome Atlas (TCGA), Genotype‐Tissue Expression (GTEx), Oncomine and Tumor Immune Estimation Resource (TIMER2) database.
Results
AQP9 was overexpressed in most tumors, while its expression was reduced in cholangiocarcinoma (CHOL), hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), lung squamous carcinoma (LUSC) and prostate adenocarcinoma (PRAD). Survival analysis revealed that elevated AQP9 levels independently predicted poor prognosis in adrenocortical carcinoma (ACC), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), lower‐grade glioma (LGG), and testicular germ cell tumors (TGCT). Importantly, AQP9 demonstrated significant correlations with tumor immune regulation, including associations with immune cell infiltration, cytokine activity, and immune checkpoint genes. Genomic alterations in AQP9 were linked to dysregulated immune pathways, and enrichment analysis highlighted its role in leukocyte migration and chemokine signaling. Furthermore, high AQP9 expression was associated with immunosuppressive tumor microenvironments, suggesting its potential to disrupt antitumor immunity.
Conclusion
Our findings suggest that elevated AQP9 levels were associated with poor prognosis and provide new insights into the dual role of AQP9 in tumor progression and immune evasion.
Zitieren
APA
Li, R., Zhang, J., Fang, X., Liu, H., Wang, Y., Jia, J., Song, Y., Zhang, W., & Liu, J. (2025). Pan‐Cancer Analysis of the Prognostic and Immunological Role of AQP9: Friend or Foe?. Cancer Nexus. https://doi.org/10.1002/cnx2.70013
Vancouver
Li R, Zhang J, Fang X, Liu H, Wang Y, Jia J, et al. Pan‐Cancer Analysis of the Prognostic and Immunological Role of AQP9: Friend or Foe?. Cancer Nexus. 2025. doi:10.1002/cnx2.70013
BibTeX
@article{Li2025,
author = {Li, Rui and Zhang, Junwei and Fang, Xuan and Liu, Huaicun and Wang, Yueqi and Jia, Junxiao and Song, Yu and Zhang, Weiguang and Liu, Junxiu},
title = {Pan‐Cancer Analysis of the Prognostic and Immunological Role of AQP9: Friend or Foe?},
journal = {Cancer Nexus},
year = {2025},
doi = {10.1002/cnx2.70013}
}
EUVIMED